follistatin 344 vs cjc+ipa blend

follistatin 344 (F-tier) vs cjc+ipa blend (A-tier). mechanism, trials, claims vs data, dosing literature. side-by-side reference.

follistatin 344 — tier F

myostatin biology is real. retail injectable follistatin-344 has zero human performance trials and major product-quality concerns.

myostatin biology is real. retail injectable follistatin-344 has zero human performance trials and well-documented product-quality problems.

myostatin 0 trials on the retail vial · half-life reported variable; reliable PK data in humans for performance doses is absent · growth hormone

cjc+ipa blend — tier A

clinic-standard GH-axis pairing. cjc-1295 + ipamorelin. receptor logic first, blend trial evidence still thin.

the most common peptide-clinic GH-axis stack. CJC-1295 + ipamorelin amplifies pulse amplitude through two separate receptors.

PCAC '24 503A excluded · half-life CJC-1295: 30 min (no DAC); ipamorelin: ~2 h · growth hormone

at a glance

• follistatin 344: tier F · myostatin 0 trials on the retail vial
• cjc+ipa blend: tier A · PCAC '24 503A excluded

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.